Abstract:Glaucoma research in China has been booming in recent years. The research involves from gene mapping and functional assessment to surgical treatment using phaco alone, trabeculectomy or phaco-trabeculectomy in angle closure glaucoma.1,2 The Panel of Glaucoma of the Chinese Ophthalmological Society has established the diagnosis and classification system for glaucoma with reference to the Preferred Practice Pattern (PPP) introduced by the American Academy of Ophthalmology in 2005. This effort enforces the improvement of the evidence-based classification system.3 Neuroprotection and optic nerve regeneration by stem cells and tissues engineering, and bleb fibrosis modulation using transgene and RNAi techniques have been the focus of forefront research in addition to the increased number of epidemiological studies over the years.4-7 The data suggest a changed spectrum of the disease.8-10 In collaboration with the British and American colleagues, ophthalmologists of the Department of Preventive Ophthalmology, Zhongshan Ophthalmic Center conducted a glaucoma survey in adult residents aged 50 years in Guangzhou. In 1405 of 1864 subjects, 53 were glaucoma cases. In these cases, 21 had primary angle closure glaucoma (PACG), 29 primary open angle glaucoma (POAG), suggesting a prevalence of 3.8%. The survey indicated that POAG is as common as PACG. The current status of glaucoma research in China can be characterized by an increasing number of papers published in international peer-reviewed journals, which provide some insights into this field in China. Definitely, we have a long way to go in clinical and basic studies of the disease. We have the largest population of angle closure glaucoma patients in the world, but the research in this field is not outstanding, especially in epidemiology using international standard, early diagnostic technology, novel surgery and medication, gene therapy, animal modeling, natural artificial vision, etc. In future, what are the priorities given to the research areas in China? The foremost is the establishment of the evidence-based system for diagnosis, prevention and treatment of glaucoma, which is suitable to areas or districts with different socioeconomic status and medical resources. The system is derived from evidence of large-scale, prospective, multi-center clinical trials and population-based studies. Besides, the association of central corneal thickness and intraocular pressure (IOP) needs to be confirmed in addition to the clinical significance of long- or short-term fluctuation, diurnal variation of IOP, individual pressure, target pressure in the glaucoma control. Imaging technology in the early diagnosis and prognosis of glaucoma is considered as important as novel filtration surgery using EX-PRESS miniature drainage implant, SOLX Gold Micro-shunt, without filtering bleb and wound healing modulation using a siRNA nanotechnology delivery system, which have been improved successful in glaucoma surgery. The diversified gene pools of people in China offer a great opportunity for effective gene mapping and its functional study. Application of functional magnetic resonance and two-photon excitation laser scanning microscopy techniques to detect changes in the retina, LGN and visual cortex is promising in unveiling the contribution of the visual pathway to the mechanism of glaucoma. Natural glaucoma experiment model using primates, which is the ideal way to mimic the development and natural history of glaucoma, hopefully offers a unique approach to selecting optimal treatment strategies. Stem cell and tissue engineering are new areas for the neuroprotection and regeneration of optic nerve damage from glaucoma. Sub-retinal or pre-retinal implantation of artificial vision prosthesis assisted by computer chip technology will help to recover partial visual function in patients with complete visual loss due to glaucoma. Investigators in China should identify appropriate priorities in the field of glaucoma based on their medical resources and experience. Equal attention should be given to make sure that the glaucoma practice is high-standard and evidence-based. Glaucoma care should also be accessible, affordable and acceptable (3A criteria) for majority of patients.

Posttraumatic glaucoma in southern China: A ten-year retrospective study

Clinical Characteristics and Prognostic Factors of Posterior Segment Intraocular Foreign Body in a Tertiary Hospital

Outcomes and Prognostic Factors of Posttraumatic Endophthalmitis: A Three-Year Retrospective Study

Epidemiological and clinical characteristics of open globe injuries in Southwest China

Characteristics and Visual Outcomes of Patients Hospitalized for Ocular Trauma in Central China: 2006-2011

Pediatric Posttraumatic Endophthalmitis In China For Twenty Years

Intraocular Foreign Bodies in China: Clinical Characteristics, Prognostic Factors, and Visual Outcomes in 1421 Eyes

Epidemiology and Clinical Characteristics of Patients with Glaucoma: an Analysis of Hospital Data Between 2003 and 2012

Ocular Injury Resulting in Eye Removal at a Large Tertiary Care Center in China.

Epidemiology, Clinical Characteristics, and Visual Outcomes of Patients with Intraocular Foreign Bodies in Southwest China: A 10-Year Review

Combined Trabeculectomy and Vitrectomy for Intractable Glaucoma with Severe Ocular Contusion Involving the Posterior Segment.

China Glaucoma Treatment Pattern Study I-Primary Angle-Closure Glaucoma: protocol for a multicentre, retrospective, observational study

What Should Be Done in Glaucoma Research in China

Clinical analysis of secondary glaucoma associated with ocular trauma

Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study

Epidemiologic Characteristics And Outcomes Of Open Globe Injury In Shanghai

Epidemiologic characteristics of 10 years hospitalized patients with glaucoma at shanghai eye and ear, nose, and throat hospital

Prognostic Factors for Open Globe Injuries and Correlation of Ocular Trauma Score in Tianjin, China

Rural Glaucoma in China: Present Status and Future Directions

Efficacy and Safety of 23-Gauge Pars Plana Vitrectomy/Silicone Oil Tamponade Combination for Treatment of Pediatric Post-Traumatic Endophthalmitis

Retrospective Clinical Analysis of 118 Cases with Malignant Glaucoma